- Home
- HOFT vs KYTX Comparison
HOFT vs KYTX Comparison
Compare HOFT & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOFT
- KYTX
- Stock Information
- Founded
- HOFT 1924
- KYTX 2018
- Country
- HOFT United States
- KYTX United States
- Employees
- HOFT N/A
- KYTX N/A
- Industry
- HOFT Home Furnishings
- KYTX
- Sector
- HOFT Consumer Discretionary
- KYTX
- Exchange
- HOFT Nasdaq
- KYTX NYSE
- Market Cap
- HOFT 119.9M
- KYTX 119.7M
- IPO Year
- HOFT 1999
- KYTX 2024
- Fundamental
- Price
- HOFT $11.47
- KYTX $4.33
- Analyst Decision
- HOFT
- KYTX Strong Buy
- Analyst Count
- HOFT 0
- KYTX 5
- Target Price
- HOFT N/A
- KYTX $19.00
- AVG Volume (30 Days)
- HOFT 159.0K
- KYTX 602.8K
- Earning Date
- HOFT 09-04-2025
- KYTX 08-11-2025
- Dividend Yield
- HOFT 8.02%
- KYTX N/A
- EPS Growth
- HOFT N/A
- KYTX N/A
- EPS
- HOFT N/A
- KYTX N/A
- Revenue
- HOFT $389,210,000.00
- KYTX N/A
- Revenue This Year
- HOFT $1.35
- KYTX N/A
- Revenue Next Year
- HOFT $8.73
- KYTX N/A
- P/E Ratio
- HOFT N/A
- KYTX N/A
- Revenue Growth
- HOFT N/A
- KYTX N/A
- 52 Week Low
- HOFT $7.34
- KYTX $1.78
- 52 Week High
- HOFT $19.79
- KYTX $10.08
- Technical
- Relative Strength Index (RSI)
- HOFT 58.90
- KYTX 63.84
- Support Level
- HOFT $10.50
- KYTX $3.80
- Resistance Level
- HOFT $11.49
- KYTX $4.39
- Average True Range (ATR)
- HOFT 0.43
- KYTX 0.39
- MACD
- HOFT 0.01
- KYTX 0.05
- Stochastic Oscillator
- HOFT 89.81
- KYTX 93.78
About HOFT Hooker Furnishings Corporation
Hooker Furnishings Corp is a designer, marketer and importer of casegoods (wooden and metal furniture), leather furniture, fabric-upholstered furniture, lighting, accessories, and home decor for the residential, hospitality and contract markets. It is also domestically manufactured premium residential custom leather, custom fabric-upholstered furniture, and outdoor furniture. The company operates in four segment Hooker Branded segment, Home Meridian segment, Domestic Upholstery segment and All Other.
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product, KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.